Tumapon, Baby Boy -.

HRN: 23-76-05  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/29/2023
CEFTAZIDIME 1GM (VIAL)
09/29/2023
10/05/2023
IV
96mg
Q12h
Potentially Septic Newborn
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: